Cargando…
Passive antibody therapy in COVID-19
For over a century, transfusion of convalescent plasma from recovered individuals has been tried as a therapeutic approach when a novel pathogen emerges. As the world awaits SARS-CoV-2 vaccines to be tested and safely deployed, the rapidity with which antiviral monoclonal antibodies can be isolated...
Autor principal: | Abraham, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290146/ https://www.ncbi.nlm.nih.gov/pubmed/32533109 http://dx.doi.org/10.1038/s41577-020-0365-7 |
Ejemplares similares
-
Smart toilets for monitoring COVID-19 surges: passive diagnostics and public health
por: Ge, T. Jessie, et al.
Publicado: (2022) -
Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022) -
COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020) -
The potential danger of suboptimal antibody responses in COVID-19
por: Iwasaki, Akiko, et al.
Publicado: (2020) -
Do cross-reactive antibodies cause neuropathology in COVID-19?
por: Kreye, Jakob, et al.
Publicado: (2020)